Roquefort Therapeutics (LON:ROQ) Shares Down 1.1%

Roquefort Therapeutics plc (LON:ROQ)’s stock price was down 1.1% during trading on Thursday . The stock traded as low as GBX 4.50 ($0.06) and last traded at GBX 4.50 ($0.06). Approximately 332,329 shares changed hands during mid-day trading, an increase of 4% from the average daily volume of 319,000 shares. The stock had previously closed at GBX 4.55 ($0.06).

Roquefort Therapeutics Stock Performance

The stock has a market cap of £6.13 million, a PE ratio of -381.25 and a beta of -0.03. The company’s 50 day simple moving average is GBX 6.82 and its 200 day simple moving average is GBX 6.95.

Roquefort Therapeutics Company Profile

Roquefort Therapeutics plc, a biotechnology company, engages in the development of medicines for the treatment of cancer. The company's pre-clinical development pipeline comprises Midkine antibodies with significance in vivo efficacy and toxicology studies; Midkine RNA therapeutics with novel anti-cancer gene editing action; Midkine mRNA therapeutics with novel anti-cancer approach; STAT-6 siRNA therapeutics targeting solid tumors with significance in vivo efficacy; and MK cell therapy with direct and NK-mediated anti-cancer action.